Pharmafile Logo
Pharmafocus logo
Advanced Search

Open Orphan signs £10.4 million contract with global pharma client

August 23, 2022
Manufacturing and Production

Open Orphan has announced that its subsidiary hVIVO has signed a £10.4 million contract with an unnamed major global pharmaceutical …

News

UK to offer mini dose of monkeypox jab amid low stocks

August 23, 2022
Manufacturing and Production

Three NHS sites will begin a pilot offering eligible patients smaller doses of monkeypox vaccine, following global shortages of the …

News

Initiative to improve next generation cancer diagnostics

August 23, 2022
Manufacturing and Production

The Medical Device Innovation Consortium (MDIC) has formally launched its Somatic Reference Samples (SRS) Initiative with a pilot project, aiming …

News

Dengue vaccine approved in Indonesia regardless of prior exposure

August 23, 2022
Manufacturing and Production

Takeda have announced the dengue vaccine, QDENGA®, was approved by the Indonesia National Agency for Drug and Food Control. Dengue …

News

Approval of only twice-yearly HIV treatment option

August 22, 2022
Sales and Marketing

The European Commission (EC) has granted a Marketing Authorisation for Sunlenca (lenacapavir) injection and tablets for the treatment of HIV …

News

NICE issues positive appraisal document for combination treatment for advanced kidney cancer

August 22, 2022
Sales and Marketing

NICE has published an appraisal consultation document (ACD) recommending the use of lenvatinib as a therapeutic option for untreated intermediate …

News

EMA accept marketing authorisation application for invasive candidiasis treatment

August 22, 2022
Sales and Marketing

The EMA has accepted the marketing authorisation application (MAA) for rezafungin, for the treatment of invasive candidiasis in adult patients. …

News

New WHO recommendations for Ebola treatments and improved access

August 22, 2022
Sales and Marketing

WHO has published its first guideline for Ebola virus disease therapeutics, calling on the global community to increase access to …

News
mosquito-g4c5e34fdf_1280

GSK awarded UNICEF contract for malaria vaccine

August 19, 2022
Medical Communications

In 2020, nearly half a million children died from malaria in Africa alone, a rate of one child death per …

News

New COVID-19 study from The Lancet Psychiatry journal shows higher risk of brain fog

August 19, 2022
Medical Communications

The study also found that adults faced an increased risk of anxiety and depression, but this subsided within two months …

News
abstract-g7ff383c53_1920

Home-based brain stimulation study on stroke survivors finds mixed results

August 19, 2022
Medical Communications

26 stroke survivors were given four weeks of remotely supervised transcranial direct current stimulation (RS-tDCS) in an at-home cognitive rehabilitation …

News

Jazz Pharmaceuticals takes groundbreaking epilepsy drug Epidiolex for adolescents into phase III trial

August 19, 2022
Medical Communications

The phase III trials will assess Epidiolex over 14 weeks in a randomised, double-blind, placebo-controlled study, enrolling paediatric patients aged …

News

GSK’s new drug application for momelotinib accepted by FDA

August 18, 2022
Business Services

The potential drug treatment is for myelofibrosis patients with anaemia UK-based GSK has announced that the US Food and Drug …

News
asthma-938695_960_720

NHS Scotland recommends Chiesi’s Trimbow for asthma

August 18, 2022
Business Services

In the UK, 5.4 million people are currently receiving treatment for asthma Chiesi Limited has announced that the Scottish Medicines …

News
cold-3835499_960_720

Newly discovered peptide shows promising results in preventing seizures; a potential future treatment for epilepsy and Alzheimer’s

August 18, 2022
Business Services

A study published in The American Society for Clinical Investigation highlights developments made by researchers to develop A1R-CT, a peptide …

News
eeg

New method involving musical tests can enable early detection of cognitive decline

August 18, 2022
Business Services

Researchers at Tel Aviv University have created a method which uses musical tests and a portable brain activity-measuring device to …

News
dna-g009a668c7_1280

Evonetix commences access programme for synthesised DNA

August 17, 2022
Research and Development

Researchers are invited to apply to receive DNA that has been synthesised using Evonetix’s platform Evonetix has announced the opening …

News

Lynparza combination therapy gets FDA priority review for prostate cancer

August 17, 2022
Research and Development

Lynparza is being jointly developed by UK-based AstraZeneca and MSD AstraZeneca’s supplemental new drug application for Lynparza (olaparib) in combination …

News
surgery-1822458_960_720

Successful study to change the blood type of donor kidneys means access for more BAME recipients

August 17, 2022
Research and Development

Scientists at the University of Cambridge have successfully altered the blood type of donor kidneys in a study which could …

News
istockphoto-1266494637-170667a

Patient with HNSCC dosed with triple combination therapy in Phase II of Genexine clinical trial

August 17, 2022
Research and Development

Genexine, a South Korean clinical-staged biopharmaceutical company, have announced the dosing with triple combination therapy of the first patient with …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025